Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
The Lupus Foundation of America announces six recipients of the 2022 Gina M. Finzi Memorial Student Summer Fellowship Program, which provides grant...
The Lupus Foundation of America's 2022 Digital Lupus Advocacy Summit, which took place June 27-29, united thousands of lupus advocates from across...
The Lupus Foundation of America is leading the effort to Make Lupus Visible throughout the month of May for Lupus Awareness Month as it rallies...
The Lupus Foundation of America celebrated the many incredible people making a difference for those living with lupus at its "Lupus Leaders...
Today, the Lupus Foundation of America (LFA) announced the launch of Strategies to Embrace Living with Lupus Fearlessly (SELF), a new online...
The Lupus Foundation of America (LFA) announced today it has been awarded a new grant from the Office of Minority Health (OMH) at the U.S. Department ...
The Lupus Foundation of America (LFA) announced today the recipients of its most prestigious annual awards, naming Richard A. Furie, MD, Northwell...
Findings from a new study of more than 1,300 people with lupus show that several barriers to care can impact a lupus diagnosis. The study, conducted...
The Lupus Foundation of America (LFA) will be presenting findings from a program evaluation of Strategies to Embrace Living with Lupus Fearlessly...
The Lupus Foundation of America is proud to announce the recipients of the 2021 Gary S. Gilkeson Career Development Award (CDA), a two-year grant...
The Lupus Foundation of America will host the world's largest lupus walk program, Walk to End Lupus Now®, on October 16, 2021. Amid the ongoing...
Today, the Lupus Foundation of America and Lupus Canada announced Zahi Touma, MD, PhD, Associate Professor of Medicine with the University of...
The U.S. Food and Drug Administration (FDA) has approved Saphnelo™ (anifrolumab-fnia) as a treatment for adults with systemic lupus erythematosus...
Today, the Lupus Foundation of America announced six recipients of the 2021 Gina M. Finzi Memorial Student Summer Fellowship Program. The fellowship...
Findings from a study of 500 people with lupus published in Rheumatology and Therapy indicate a high level of burden with current treatments and...
This May for Lupus Awareness Month, the Lupus Foundation of America will continue its effort to Make Lupus Visible, encouraging lupus warriors,...
The Lupus Foundation of America is pleased to announce a new three-year grant, funded by the Festa Family Foundation, supporting the IMPACT study...
The Lupus Foundation of America is excited to launch its free, live educational series Lupus & You: Answers. Advocacy. Action. where people with...
The Lupus Foundation of America's 2021 Digital Lupus Advocacy Summit brought together thousands of lupus advocates from across the country to...
The Lupus Foundation of America (LFA) announced today the recipients of its most prestigious annual awards, recognizing three leading lupus...
For the second time in less than two months, the U.S. Food and Drug Administration (FDA) has approved a new medication to treat adults with lupus...
The U.S. Food and Drug Administration (FDA) has approved Benlysta to treat lupus nephritis (lupus-related kidney disease) in adults. The approval is...
The Lupus Foundation of America (LFA) will be presenting on the feasibility and acceptability of their new self-management resource, Take Charge, and ...
Today, the Lupus Foundation of America announced the launch of RAY: Research Accelerated by You, a new lupus data platform where people with lupus...
Today, the Lupus Foundation of America (LFA) and the American Academy of Family Physicians (AAFP) announced a collaboration to ensure family...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.